Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CELSION CORPORATION

(CLSN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
1.41(c) 1.31(c) 1.32(c) 1.32(c) 1.24(c) Last
5 714 656 2 840 958 1 697 593 1 122 415 1 940 945 Volume
-8.44% -7.09% +0.76% 0.00% -6.06% Change
More quotes
Financials (USD)
Sales 2021 - - -
Net income 2021 -22,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,13x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -23,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 -4,77x
Yield 2022 -
Capitalization 107 M 107 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 27
Free-Float 99,5%
More Financials
Company
Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid... 
More about the company
All news about CELSION CORPORATION
06/10CELSION  : Appoints Dr. Stacy R. Lindborg to its Board of Directors (Form 8-K)
PU
06/10CELSION CORP  : Change in Directors or Principal Officers, Submission of Matters..
AQ
06/09Celsion Appoints Christine A. Pellizzari to its Board of Directors
GL
06/08CELSION CORPORATION  : Appoints Dr. Stacy R. Lindborg to its Board of Directors
AQ
06/07CELSION  : ANNOUNCES ADJOURNMENT OF ANNUAL MEETING (Form 8-K)
PU
06/07CELSION CORP  : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/07Celsion corporation announces adjournment of annual meeting
GL
06/04CELSION  : ANNOUNCES ADJOURNMENT OF ANNUAL MEETING (Form 8-K)
PU
06/04Celsion corporation announces adjournment of annual meeting
GL
06/04CELSION CORP  : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/02CELSION CORPORATION  : Urges All Shareholders to Vote at the 2021 Annual Meeting..
AQ
05/27Celsion Corporation Urges All Shareholders to Vote at the 2021 Annual Meeting..
GL
05/14CELSION  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
05/14CELSION CORP  : Results of Operations and Financial Condition, Financial Stateme..
AQ
05/14Celsion Corporation Reports First Quarter 2021 Financial Results and Provides..
GL
More news
News in other languages on CELSION CORPORATION
01/21MÄRKTE USA/Nach neuen Hochs geht Wall Street die Luft aus
More news
Chart CELSION CORPORATION
Duration : Period :
Celsion Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELSION CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 4,00 $
Last Close Price 1,24 $
Spread / Highest target 223%
Spread / Average Target 223%
Spread / Lowest Target 223%
EPS Revisions
Managers and Directors
NameTitle
Michael H. Tardugno Chairman, President & Chief Executive Officer
Jeffrey Wayne Church CFO, Secretary & SVP-Investor Relations
Nicholas Borys Chief Medical Officer & Senior Vice President
Khursheed Anwer Chief Scientific Officer & Executive VP
Pok Yu Chow Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CELSION CORPORATION74.40%107
GILEAD SCIENCES, INC.14.33%83 541
WUXI APPTEC CO., LTD.24.70%63 775
REGENERON PHARMACEUTICALS11.35%55 705
BIONTECH SE160.57%51 304
VERTEX PHARMACEUTICALS-20.52%48 628